NIAID Banner Logo Image


1. 47744 OI-LS-328; PUBMED-OI-8/8/2005

Antifungal Agents. 11. N-Substituted Derivatives of 1-[(Aryl)(4-aryl-1H-pyrrol-3-yl)methyl]-1H-imidazole: Synthesis, Anti-Candida Activity, and QSAR Studies

Di Santo, R, Tafi, A, Costi, R, Botta, M, Artico, M, Corelli, F, Forte, M, Caporuscio, F, Angiolella, L, and Palamara, AT

J Med Chem 2005. 48(16): 5140-5153


2. 47745 OI-LS-328; PUBMED-OI-8/8/2005

Design and Synthesis of Depeptidized Macrocyclic Inhibitors of Hepatitis C NS3-4A Protease Using Structure-Based Drug Design

Venkatraman, S, Njoroge, FG, Girijavallabhan, VM, Madison, VS, Yao, NH, Prongay, AJ, Butkiewicz, N, and Pichardo, J

J Med Chem 2005. 48(16): 5088-91


3. 47746 OI-LS-328; PUBMED-OI-8/8/2005

Deletion of the Mycobacterium tuberculosis pknH Gene Confers a Higher Bacillary Load during the Chronic Phase of Infection in BALB/c Mice

Papavinasasundaram, KG, Chan, B, Chung, JH, Colston, MJ, Davis, EO, and Av-Gay, Y

J Bacteriol 2005. 187(16): 5751-60


4. 47747 OI-LS-328; EMBASE-OI-8/8/2005

Synthesis of some novel benzoxazole derivatives as anticancer, anti-HIV-1 and antimicrobial agents

Rida, Samia M, Ashour, Fawzia A, El-Hawash, Soad AM, ElSemary, Mona M, Badr, Mona H, and Shalaby, Manal A

European Journal of Medicinal Chemistry 2005. In Press, Corrected Proof


5. 47748 OI-LS-328; PUBMED-OI-8/8/2005

Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo

Mui, EJ, Jacobus, D, Milhous, WK, Schiehser, G, Hsu, H, Roberts, CW, Kirisits, MJ, and McLeod, R

Antimicrob Agents Chemother 2005. 49(8): 3463-3467


6. 47749 OI-LS-328; PUBMED-OI-8/8/2005

Correspondence of in vitro and in vivo fluconazole dose-response curves for Cryptococcus neoformans

Larsen, RA, Bauer, M, Thomas, AM, Sanchez, A, Citron, D, Rathbun, M, and Harrison, TS

Antimicrob Agents Chemother 2005. 49(8): 3297-3301


7. 47750 OI-LS-328; PUBMED-OI-8/8/2005

Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis

Maus, CE, Plikaytis, BB, and Shinnick, TM

Antimicrob Agents Chemother 2005. 49(8): 3192-7


8. 47751 OI-LS-328; PUBMED-OI-8/8/2005

Antiviral drug discovery and development: Where chemistry meets with biomedicine

De Clercq, E

Antiviral Res 2005.


9. 47752 OI-LS-328; PUBMED-OI-8/8/2005

Inhibition of 7,8-diaminopelargonic acid aminotransferase by amiclenomycin and analogues

Mann, S, Marquet, A, and Ploux, O

Biochem Soc Trans 2005. 33(Pt 4): 802-5


10. 47753 OI-LS-328; PUBMED-OI-8/8/2005

Isoprenoid biosynthetic pathways as anti-infective drug targets

Rohdich, F, Bacher, A, and Eisenreich, W

Biochem Soc Trans 2005. 33(Pt 4): 785-91


11. 47754 OI-LS-328; PUBMED-OI-8/8/2005

Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives

Sriram, D, Yogeeswari, P, Basha, JS, Radha, DR, and Nagaraja, V

Bioorg Med Chem 2005.


12. 47755 OI-LS-328; PUBMED-OI-8/8/2005

CD43 Is Required for Optimal Growth Inhibition of Mycobacterium tuberculosis in Macrophages and in Mice

Randhawa, AK, Ziltener, HJ, Merzaban, JS, and Stokes, RW

J Immunol 2005. 175(3): 1805-12


13. 47756 OI-LS-328; PUBMED-OI-8/8/2005

Molecular virology of the hepatitis C virus: implication for novel therapies

Glenn, JS

Clin Liver Dis 2005. 9(3): 353-69


14. 47757 OI-LS-328; WOS-OI-7/31/2005

TB and phenothiazines

Amaral, L

SCIENTIST 2005. 19(14): 8-1


15. 47758 OI-LS-328; WOS-OI-7/31/2005

Identification of phthiodiolone ketoreductase, an enzyme required for production of mycobacterial diacyl phthiocerol virulence factors

Onwueme, KC, Vos, CJ, Zurita, J, Soll, CE, and Quadri, LEN

JOURNAL OF BACTERIOLOGY 2005. 187(14): 4760-4766, 7


16. 47759 OI-LS-328; EMBASE-OI-8/8/2005

Antiviral therapy of congenital cytomegalovirus infection

Schleiss, Mark R

Seminars in Pediatric Infectious Diseases 2005. 16(1): 50-59


17. 47760 OI-LS-328; WOS-OI-7/31/2005

Initial results of a phase 1B, multiple-dose study of VX-950, a hepatitis C virus protease inhibitor

Reesink, HW, Zeuzem, S, van Vliet, A, McNair, L, Purdy, S, Chu, HM, and Jansen, PL

GASTROENTEROLOGY 2005. 128(4): A697-1


18. 47761 OI-LS-328; WOS-OI-7/31/2005

Winnowing out drug candidates

Yarnell, A

CHEMICAL & ENGINEERING NEWS 2005. 83(28): 28-30, 3


19. 47762 OI-LS-328; WOS-OI-8/7/2005

Complete replication of hepatitis C virus in cell culture

Lindenbach, BD, Evans, MJ, Syder, AJ, Wolk, B, Tellinghuisen, TL, Liu, CC, Maruyama, T, Hynes, RO, Burton, DR, McKeating, JA, and Rice, CM

SCIENCE 2005. 309(5734): 623-626, 4


20. 47763 OI-LS-328; WOS-OI-8/7/2005

Characterization of intracellular activity of antitubercular constituents from the roots of Euclea natalensis

Lall, N, Meyer, JJM, Wang, Y, Bapela, NB, van, Rensburg CEJ, Fourie, B, and Franzblau, SG

PHARMACEUTICAL BIOLOGY 2005. 43(4): 353-357, 5


21. 47764 OI-LS-328; WOS-OI-8/7/2005

Amino acid ester prodrugs of 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl) benzimidazole enhance metabolic stability in vitro and in vivo

Lorenzi, PL, Landowski, CP, Song, XQ, Borysko, KZ, Breitenbach, JM, Kim, JS, Hilfinger, JM, Townsend, LB, Drach, JC, and Amidon, GL



If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2024